Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Shareholders' Equity (Unaudited)

v3.22.1
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 91,767 $ 7,174,854 $ 164,022,957 $ (154,444,983) $ 16,844,595
Beginning Balance, shares at Dec. 31, 2020 91,766,928 16,017,133.483      
Compensation expense relating to option issuances 1,123,761 1,123,761
Net loss (5,219,945) (5,219,945)
Series C dividend $ 1,117,531 (1,117,531)
Series C dividend, shares   33.016      
Series C redemption   $ (5,635,672)     (5,635,672)
Series C Redemption, shares   (166.499)      
ATM offering - net of expenses $ 21,399 26,654,993 26,676,392
ATM offering - net of expenses, shares 21,398,765        
Issuance of common stock from warrant exercise $ 2,472 2,258,864 2,261,336
Issuance of common stock from warrant exercise, shares 2,472,573        
Ending balance, value at Mar. 31, 2021 $ 115,638 $ 2,656,713 194,060,575 (160,782,459) 36,050,467
Ending Balance, shares at Mar. 31, 2021 115,638,266 16,017,000.000      
Beginning balance, value at Dec. 31, 2021 $ 116,395 $ 2,656,713 194,987,219 (171,274,128) 26,486,199
Beginning Balance, shares at Dec. 31, 2021 116,394,806 16,017,000.000      
Compensation expense relating to option issuances 90,247 90,247
Net loss (6,035,394) (6,035,394)
Ending balance, value at Mar. 31, 2022 $ 116,395 $ 2,656,713 $ 195,077,466 $ (177,309,522) $ 20,541,052
Ending Balance, shares at Mar. 31, 2022 116,394,806 16,017,000.000